STOCKHOLM (Reuters) -Danish drugmaker Novo Nordisk said on Thursday it had agreed to buy United States based Akero Therapeutics, a clinical-stage company developing innovative treatments for patients
Novo Nordisk buys Akero Therapeutics in the US
Overview of the Acquisition
STOCKHOLM (Reuters) -Danish drugmaker Novo Nordisk said on Thursday it had agreed to buy United States based Akero Therapeutics, a clinical-stage company developing innovative treatments for patients with serious metabolic diseases marked by a high unmet medical need.
Details of the Deal
(Reporting by Anna Ringstrom, editing by Essi Lehto)





